Two patients are described who had clinical anaphylaxis due to muscle relaxants. One patient had systemic hypersensitivity and positive intradermal tests to d-tubocurarine and alcuronium. The second had systemic hypersensitivity to d-tubocurarine and positive intradermal tests to d-tubocurarine, alcuronium, and pancuronium. It is suggested that positive intradermal tests to more than one relaxant may mean allergy to more than one relaxant rather than false positive test. Cross sensitivity between alcuronium and d-tubocurarine occurs and a similar situation may exist for suxamethonium and gallamine. When intradermal testing is carried out after anaesthetic reactions all relaxants should be tested.
INTRODUCTION
Intradermal testing is a reliable method of determining the drug responsible for an acute anaphylactic reaction occurring during induction of anaesthesia I • However false positive reactions due to direct histaminereleasing effect, and false negative reactions may occur.
On occasions positive intradermal tests to both gallamine and suxamethonium, and alcuronium and d-tubocurarine have been noted. This paper provides evidence that in the case of these two pairs of drugs, positive skin tests may represent cross sensitivity between the drugs.
Detailed investigations and case histories of two patients are presented. A retrospective analysis of patients previously studied is given. Patients were tested intradermally according to the protocol described by Fisher l •
Case 1
A healthy 30-year-old woman was anaesthetised for septoplasty. She had no history of atopic disease or drug allergy. She had had two previous anaesthetics for Caesarian section using thiopentone, suxamethonium and d-tubocurarine. The first anaesthetic was uneventful. After induction on the second occasion she developed hypotension, tachycardia, cyanosis and bronchospasm which was treated with dexamethasone and intravenous fluids. She had no other history of drug allergy. Because of the previous reaction, on this third occasion she was initially given an uneventful test dose of propanidid 50 mg and after two minutes was induced with propanidid 400 mg and alcuronium 20 mg.
After 30 seconds her electrocardiogram (ECG) showed sinus tachycardia 140 beats/min and she was difficult to ventilate. She was rapidly intubated and commenced on intermittent positive pressure ventilation (lPPV) with 100% oxygen. She became cyanosed, vasodilated and warm and her pulse could be palpated with difficulty. She was given a rapid infusion of Ringer's lactate solution 1000 ml, 4 ml of 1 :20,000 adrenaline in divided dosage, and external cardiac massage and her colour improved. Her bronchospasm was relieved by intravenous (IV) aminophylline 100 mg. Her condition improved slowly and after 30 minutes blood pressure (BP) was 80 mmHg systolic. Her ECG throughout showed sinus tachycardia. She was given neostigmine 2.5 mg and atropine 1.25 mg and was conscious but drowsy after extubation. In the recovery room it was noted that she had swelling of the eyelids and upper lip and she was given dexamethasone 8 mg. Four hours after commencement of anaesthesia she had made a complete recovery.
Intradermal testing was carried out one month after the reaction. The results are shown in Table 1 .
PK testing in macaca neministrina monkeys was positive for alcuronium and d-tubocurarine.
Resting levels of C3 and C4 and IgA, IgM, IgG were normal. IgE was 250 iu/ml (normal 0-200 iu). No react ion in cont foh
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Results Intradermal Testing Case I
Case 2
A healthy 21-year-old male with a past history of allergy to blueberries was anaesthetised for an elective cholecystectomy. He had not had an anaesthetic previously. Preoperative haemoglobin (Hb) was 14.7 gm/lOO ml. Premedication was papaveretum 20 mg and hyoscine 0.4 mg. He was induced with thiopentone 400 mg and d-tubocurarine 30 mg. Within 20 seconds his skin became scarlet all over; he was difficult to ventilate and developed gross facial swelling. He was rapidly intubated and commenced on IPPV with 100070 oxygen and given aminophylline 150 mg, dexamethasone 24 mg and a litre of Ringer's lactate solution. His ventilation became easier and his colour improved but the low BP persisted. He was given a rapid infusion of stable plasma protein solution 5070 (SPPS) 1500 m!.
His BP rose to 75 mmHg at 30 minutes and he was given dexamethasone 24 mg, promethazine 25 mg and he began to resist the ventilator. He was paralysed with pancuronium 4 mg and sedated with diazepam 10 mg and transferred to Royal North Shore Hospital by ambulance. On arrival 30 minutes later he had marked peripheral vasoconstriction, BP 150/80 mmHg and was resisting the ventilator. He was given atropine 1.2 mg and neostigmine 2.5 mg and extubated. Hb was 17.2 g/ lOOm!. He was given a further 500 ml of SPPS over two hours which improved his peripheral circulation and lowered Hb to 15.2 g/100 m!. A diuresis commenced. Four hours after induction he was well although facial oedema persisted for two days. He was discharged the following morning.
Intradermal testing was carried out one month after the reaction. The results are shown in Table 2 .
Classical pathway activation occurred during the reaction. PK testing in macaca neministrina monkeys was positive to d-tubocurarine only. Resting levels of C3, C4, IgA, IgM and IgG were normal. IgE was greater than 1000 iu/ml (normal 0-200 iu/ml). TAillE 
DISCUSSION
Three previous patients who have been tested intradermally after reactions to d-tubocurarine had positive intradermal tests. In two patients tests to alcuronium were negative and in one alcuronium was not tested.
Nine previous patients have had positive intradermal tests to alcuronium after reactions to alcuronium, and only one of these had a Anaesthesia and Intensive Care, Vol. VIII, No. 2, May, 1980 positive intradermal test to d-tubocurarine.
Four previous patients who reacted to gallamine had positive skin tests for gallamine and negative skin tests to suxamethonium.
Four previous patients who had reactions to suxamethonium had positive skin tests to suxamethonium and two had positive skin tests to gallamine. In one patient the positive test to gallamine was negative at 1: 100,000 dilution.
Intradermal tests are suggestive of the presence of IgE 2 ,3 or IgG 4 antibodies. It is however difficult to confirm the involvement of such antibodies in reactions to anaesthesia 5 , although IgE has been shown to be involved in some reactions, and positive PK and other tests to detect antibodies have on occasions been positive 6 ,7,8. Irrespective of the mechanism of a positive intradermal test, it is well established that patients who react to muscle relaxants will give positive wheal and flare reactions at much lower concentrations than normal subjects 5 • Our own observations of 70 reactors and over 100 nonreactors further suggest that the wheal and flare reactions in normal subjects arise immediately and seldom persist longer than 20 minutes, whereas those in reactors arise over 5-10 minutes and may persist up to eight hours.
The first patient had a reaction to both d-tubocurarine and alcuronium and this was confirmed by intradermal testing and PK testing. Clinical reactions to both drugs correlating with intradermal testing has been described previously9.
The second case showed sensItIvIty to d-tubocurarine, alcuronium and pancuronium with only the d-tubocurarine confirmed by PK testing, However as negative PK tests may not mean absence of true sensitivityS and as positive responses were produced to alcuronium and pancuronium at a dilution of the order of 10-4, the concentration producing wheal and flare reactions in volunteers, we believe that this patient should not have these drugs on a subsequent occasion. This situation was further complicated by the patient receiving pancuronium uneventfully during resuscitation. However immediately after anaphylaxis a second antigenic challenge may be ineffective due to mediator depletion. Clinical reactions to suxamethonium and gallamine in the same patient have not been described, Two of our patients have demonstrated cutaneous hypersensitivity to both drugs and this has been noted in one patient in the literature lO • However, in the absence of documented clinical reactions to both drugs it must be emphasised that the case for cross-sensitivity between gallamine and suxamethonium is purely circumstantial.
Cross-sensitivity has been postulated as a cause of anaphylaxis on first exposure due to muscle relaxants 8 • It appears in addition that cross-sensitivity between relaxants may occur although not in all patients.
Patients who react to muscle relaxants should be intradermally tested to all muscle relaxants and those relaxants giving positive results not used in future anaesthesia. It further appears that both alcuronium and d-tubocurarine, and gallamine and suxamethonium should be used with care, if at all, if a reaction has occurred to one member of the pair.
